Cargando…

Nine-year survival after iterative metastasectomies for renal cell carcinoma

We report the case of a 24-year-old male, diagnosed with an incidental T3a papillary renal cell carcinoma (RCC), treated with left laparoscopic radical nephrectomy. After 7 months, nodal recurrence was identified and retroperitoneal lymph node dissection (RPLND) was performed. Four months later, due...

Descripción completa

Detalles Bibliográficos
Autores principales: de Oliveira, Tiago Ribeiro, Ouattara, Adama, Everaerts, Wouter, De Meerleer, Gert, Joniau, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476217/
https://www.ncbi.nlm.nih.gov/pubmed/31040613
http://dx.doi.org/10.4103/UA.UA_53_18
_version_ 1783412866730164224
author de Oliveira, Tiago Ribeiro
Ouattara, Adama
Everaerts, Wouter
De Meerleer, Gert
Joniau, Steven
author_facet de Oliveira, Tiago Ribeiro
Ouattara, Adama
Everaerts, Wouter
De Meerleer, Gert
Joniau, Steven
author_sort de Oliveira, Tiago Ribeiro
collection PubMed
description We report the case of a 24-year-old male, diagnosed with an incidental T3a papillary renal cell carcinoma (RCC), treated with left laparoscopic radical nephrectomy. After 7 months, nodal recurrence was identified and retroperitoneal lymph node dissection (RPLND) was performed. Four months later, due to local recurrence, the patient underwent salvage RPLND, partial psoas resection and left adrenalectomy, and remained without recurrence during the following 15 months, after which treatment with sunitinib was started due to multiple metastases in pelvic lymph nodes, lungs, and bone. After 4 years of stable disease, progression at the quadratus lumborum and psoas muscles led to subsequent metastasectomy. No evidence of progression was identified for 2 years, after which, despite multimodal treatment (axitinib and radiotherapy to bone lesions), widespread disease progression led to patient death. This uncommon case of prolonged survival with metastatic RCC highlights the possible role of iterative metastasectomies in the management of advanced stage disease, as well as its potential to extend the survival substantially, even when progressive on tyrosine kinase inhibitors.
format Online
Article
Text
id pubmed-6476217
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-64762172019-04-30 Nine-year survival after iterative metastasectomies for renal cell carcinoma de Oliveira, Tiago Ribeiro Ouattara, Adama Everaerts, Wouter De Meerleer, Gert Joniau, Steven Urol Ann Case Report We report the case of a 24-year-old male, diagnosed with an incidental T3a papillary renal cell carcinoma (RCC), treated with left laparoscopic radical nephrectomy. After 7 months, nodal recurrence was identified and retroperitoneal lymph node dissection (RPLND) was performed. Four months later, due to local recurrence, the patient underwent salvage RPLND, partial psoas resection and left adrenalectomy, and remained without recurrence during the following 15 months, after which treatment with sunitinib was started due to multiple metastases in pelvic lymph nodes, lungs, and bone. After 4 years of stable disease, progression at the quadratus lumborum and psoas muscles led to subsequent metastasectomy. No evidence of progression was identified for 2 years, after which, despite multimodal treatment (axitinib and radiotherapy to bone lesions), widespread disease progression led to patient death. This uncommon case of prolonged survival with metastatic RCC highlights the possible role of iterative metastasectomies in the management of advanced stage disease, as well as its potential to extend the survival substantially, even when progressive on tyrosine kinase inhibitors. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6476217/ /pubmed/31040613 http://dx.doi.org/10.4103/UA.UA_53_18 Text en Copyright: © 2019 Urology Annals http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Report
de Oliveira, Tiago Ribeiro
Ouattara, Adama
Everaerts, Wouter
De Meerleer, Gert
Joniau, Steven
Nine-year survival after iterative metastasectomies for renal cell carcinoma
title Nine-year survival after iterative metastasectomies for renal cell carcinoma
title_full Nine-year survival after iterative metastasectomies for renal cell carcinoma
title_fullStr Nine-year survival after iterative metastasectomies for renal cell carcinoma
title_full_unstemmed Nine-year survival after iterative metastasectomies for renal cell carcinoma
title_short Nine-year survival after iterative metastasectomies for renal cell carcinoma
title_sort nine-year survival after iterative metastasectomies for renal cell carcinoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476217/
https://www.ncbi.nlm.nih.gov/pubmed/31040613
http://dx.doi.org/10.4103/UA.UA_53_18
work_keys_str_mv AT deoliveiratiagoribeiro nineyearsurvivalafteriterativemetastasectomiesforrenalcellcarcinoma
AT ouattaraadama nineyearsurvivalafteriterativemetastasectomiesforrenalcellcarcinoma
AT everaertswouter nineyearsurvivalafteriterativemetastasectomiesforrenalcellcarcinoma
AT demeerleergert nineyearsurvivalafteriterativemetastasectomiesforrenalcellcarcinoma
AT joniausteven nineyearsurvivalafteriterativemetastasectomiesforrenalcellcarcinoma